INVA FY 2016 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$134M+147.6% YoY

Gross Profit

$132M99.0% margin

Operating Income

$109M81.6% margin

Net Income

$60M44.6% margin

EPS (Diluted)

$0.53

Cash Flow

Operating Cash Flow

$61M

Free Cash Flow

$61M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$379M

Total Liabilities

$732M

Stockholders' Equity

-$353M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$134M	$54M	+147.6%
Gross Profit	$132M	$51M	+157.5%
Operating Income	$109M	$32M	+245.1%
Net Income	$60M	-$19M	+417.4%